Development of new nevi (moles) and changes to pre-existing ones Several researchers have documented cases where MT-II administration caused the development of new pigmented nevi or pre-existing nevi to grow and darken in color
[DOI] [PubMed] [Google Scholar] Diao Y, Xu H, Li G, Yu A, Yu X, Hu W, Zheng X, Li S, Wang Y, Hu Z
Quintanilha, G.A
Zn can eliminate free radicals directly through GSH or indirectly as a cofactor for GSH peroxidase [9]
FDA approval in the United States is expected in 2025-2026, with Health Canada approval typically following 6-18 months after FDA approval
However, these techniques are not universally available and costly